APOE and Alzheimer disease: Overall, AD patients displayed higher CSF Gal-3 levels compared to NC (1168.8 pg/mL versus 960.5 pg/mL, P = 0.030 adjusted for age, sex, and ApoE4 carriership Fig. 5a).